Atlas Trials

Phase 2 Study of TD-9855 to Treat Fibromyalgia

Clinical trial NCT01693692 · COMPLETED

Trial details

NCT number
NCT01693692
Sponsor
Theravance Biopharma
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Fibromyalgia
Start date
2012-11-01
Primary completion
2014-01-01
Enrollment
392

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.